Skip to content

The Effect of High-intensity Laser Therapy in Patients With Carpal Tunnel Syndrome.

The Effect of High-intensity Laser Therapy on Pain, Functional Status, Hand Grip Strength and Median Nerve Cross-sectional Area in Ultrasonography in Patients With Carpal Tunnel Syndrome.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05678595
Enrollment
60
Registered
2023-01-10
Start date
2022-12-01
Completion date
2023-06-23
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome

Keywords

pain, High-intensity laser therapy, ultrasonography

Brief summary

The aim of this study is to evaluate the effects of high intensity laser therapy (HILT) on pain, functional status, hand grip strength and median nerve cross-sectional area in ultrasonography in patients with carpal tunnel syndrome.

Detailed description

Patients who are admitted and diagnosed with carpal tunnel syndrome based on anamnesis, physical examination and electromyography are included in the study.

Interventions

HILT: A hot laser derived from a Nd: YAG laser has 12 W (watt) and 1064 nm characteristics. The device will administered to the hand wrist area in two steps in the HILT group: phase I and phase II. The application will made utilizing continuous circular movements in both phases I and II. The first five sessions consisted of a 100-second intermittent phase analgesic effect at 8 W and 8 J/cm2 for a total energy of 200 J. The following five sessions consisted of a continuous 11 minutes 6 second bio stimulating effect with a dosage of 3 W 80 J/cm2. Over the course of two weeks, ten treatment sessions of HILT will be given.

HILT is administered as a placebo for two weeks, 5 sessions a week, for a total of 10 sessions.

Sponsors

Necmettin Erbakan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Electrophysiologically mild or moderate CTS 2. Patients who are literate and able to understand verbal instructions in our

Exclusion criteria

1. Diabetes 2. Systemic disorders that may affect treatment such as hypothyroidism, SLE, gout 3. History of polyneuropathy, cervical radiculopathy, brachial plexopathy 4. Injection for the carpal tunnel in the last 1 month 5. History of severe trauma, fracture, operation to both upper extremities at any time 6. Malignancy or history of malignancy 7. Renal failure 8. Peripheral or central nervous system diseases 9. Pregnancy 10. History of physical therapy program for the same hand wrist in the last months.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS)Change from baseline in pain on the VAS at week 2 and week 12 [ Time Frame: Baseline-Week 2- Week 12 ]Visual Analog Scale (VAS) is used to measure and monitor the intensity of pain.

Secondary

MeasureTime frameDescription
Boston Carpal Tunnel QuestionnaireChange from baseline in pain and disability on the Boston Carpal Tunnel Questionnaire at week 2 and 12.The Boston Carpal Tunnel Score is a patient-reported questionnaire that examines symptom severity and overall functional status of patients with carpal tunnel syndrome. The Symptom Severity Scale (SSS) with 11 questions is scored on a Likert scale of 1-5 and the Functional Status Scale (FSS) with 8 questions is scored from 1-5 with 1 as no difficulty and 5 as difficult.
Hand Grip Force Measurement TestBaseline- week 2- week 12A hydraulic hand dynamometer (Jamar) will be used in the measurements. Three measurements will be made with the elbow flexed and connected to the body, and the forearm in a neutral position. The measurements will be averaged in kg-f and recorded in the study form.
The cross-sectional area of the median nerveChange from baseline in the cross-sectional area of the median nerve at week 2 and week 12.The cross-sectional area of the median nerve will be measured by USG at the level of the pisiform bone (proximal carpal tunnel). While the patient is in a sitting position, the arm on the measuring side will be positioned semiflexed, elbow semiflexed, forearm supinated, fingers semi-flexed, and wrist on a flat surface.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026